FDA Public Workshop: Brain-Computer Interface Devices for Patients With Paralysis and Amputation

FDA’s White Oak Campus, Silver Spring, MD

The purpose of this workshop is to obtain feedback on scientific, clinical, and regulatory considerations associated with BCI devices.  Ideas and suggestions generated during this workshop may facilitate development of draft guidance to provide our initial thoughts regarding the content of premarket submissions for emerging BCI technologies and help to speed development and approval of future submissions.

Registration information can be found on the meeting webpage.